Timeline Heading 1
The anti-cancer drug Pt1b developed by Prof. Che and his team in LSCCB has passed the IND application review in Mainland China and the clinical trials has now begun.
che
group
The investigations conducted by the Che Group have resulted in significant innovations. These include the development of novel excited-state atom transfer catalysis, selective hydrocarbon functionalization reactions, practical phosphorescent and metal-assisted TADF emitters, unique functional supramolecular metal assemblies, and anti-cancer metal medicines to combat metastatic malignancies.
The anti-cancer drug Pt1b developed by Prof. Che and his team in LSCCB has passed the IND application review in Mainland China and the clinical trials has now begun.
Prof. Che received a new plaque of the State Key Laboratory of Synthetic Chemistry at the presentation ceremony hosted by the Minister of the Ministry of Science and Technology, Mr. Yin Hejun. see: hkumedia
Prof. Che has been prominently featured in a special topic by HKTKWW
Prof. Che has been listed among the best scientists in the field of Chemistry and ranked 71st globally (5th in China) in the 3nd edition of Research.com with a D-index of 150. See: research.com/u/chi-ming-che & HKU News
Prof. Che has received funding from the Research, Academic, and Industry Sectors One-plus Scheme (RAISe+) for Innovative molecular emitters for practical OLEDs and wearable devices, details: hkumedia

Image: Yee Fong Lectureship (義芳化學講座) at National Taiwan University, Taipei, Taiwan, China, November 25, 2025
News
Publication Updates